HMCN1 c.339+5990C>T

Variant ID: 1-185821218-C-T

NM_031935.2(HMCN1):c.339+5990C>T

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer.

Frontiers In Pharmacology
Singh, Desh Deepak DD; Lee, Hae-Jeung HJ; Yadav, Dharmendra Kumar DK
Publication Date: 2022

Variant appearance in text: rs12082081
PubMed Link: 36578543
Variant Present in the following documents:
  • fphar-13-1089066.pdf
View BVdb publication page



A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting.

Pharmacoeconomics - Open
McCloskey, Conor C; Ortega, María Toboso MT; Nair, Sunita S; Garcia, Maria João MJ; Manevy, Federico F
Publication Date: 2022-08-23

Variant appearance in text: rs12082081
PubMed Link: 35996066
Variant Present in the following documents:
  • Main text
View BVdb publication page



Breast Cancer Genomics: Primary and Most Common Metastases.

Cancers
Bennett, Caroline C; Carroll, Caleb C; Wright, Cooper C; Awad, Barbara B; Park, Jeong Mi JM; Farmer, Meagan M; Brown, Elizabeth Bryce EB; Heatherly, Alexis A; Woodard, Stefanie S
Publication Date: 2022-06-21

Variant appearance in text: rs12082081
PubMed Link: 35804819
Variant Present in the following documents:
  • Main text
View BVdb publication page



Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and Challenges.

Frontiers In Oncology
Stucci, Luigia Stefania LS; Pisino, Marco M; D'Addario, Claudia C; Grassi, Teresa T; Toss, Angela A
Publication Date: 2022

Variant appearance in text: rs12082081
PubMed Link: 35664788
Variant Present in the following documents:
  • fonc-12-871160.pdf
View BVdb publication page



A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3.

Mabs
Rau, Alexander A; Kocher, Katharina K; Rommel, Mirjam M; Kühl, Lennart L; Albrecht, Maximilian M; Gotthard, Hannes H; Aschmoneit, Nadine N; Noll, Bettina B; Olayioye, Monilola A MA; Kontermann, Roland E RE; Seifert, Oliver O
Publication Date: 2021

Variant appearance in text: rs12082081
PubMed Link: 33752566
Variant Present in the following documents:
  • KMAB_13_1902034.pdf
View BVdb publication page



The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer.

Cancers
Patel, Aena A; Unni, Nisha N; Peng, Yan Y
Publication Date: 2020-07-28

Variant appearance in text: rs12082081
PubMed Link: 32731409
Variant Present in the following documents:
  • Main text
  • cancers-12-02081.pdf
View BVdb publication page